Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 10, 2026 · Filed Nov 13, 2026
An Ionis Pharmaceuticals director paid $148K out of pocket for Ionis Pharmaceuticals shares. It was the first purchase in 18 months. Shares held went up 23% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$148,200
Shares × reported transaction price
$100K–$500K
+22.7%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 18 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 3 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
1 day after results of Nov 9, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $28.19 on Nov 10, 2026, at its 52-week low, after a 39% drop over the previous 30 trading days
52-week range $28.19 (Nov 10, 2026) to $86.50 (Feb 6, 2026), 0% of the way up, from 250 adjusted closes. 30 trading days earlier: $45.89 on Sep 29, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
The first open-market purchase by any IONS insider since May 2025
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
Fund moves
From a 13F filed Nov 13, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Insider filing
Traded Oct 15 · filed 5 days later
Derivative exercise or conversion — not an open-market buy.
Eric Swayze (EVP Research) sold ~$2.3K of Ionis Pharmaceuticals
Automatic saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.